Medicare Enrolled
Dr. Brooks Cash, MD
Gastroenterology · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cash?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cash
Dr. Brooks Cash is a gastroenterology specialist in Houston, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Cash performed 358 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cash received a total of $922,233 from 47 pharmaceutical and/or device companies across 880 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cash is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ 358 Medicare services
$922,233 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗358
Medicare services
Bottom 25% in TX for gastroenterology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Esophageal motility study A test that evaluates the movement and function of the esophagus. |
72 | $50 | $400 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $71 | $317 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $109 | $456 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
39 | $142 | $519 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
25 | $77 | $978 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $84 | $283 |
| Hydrogen breath test A test that measures hydrogen levels in your breath to help evaluate stomach and bowel symptoms. |
15 | $7 | $242 |
| Rectal sensitivity and function study A test to evaluate the sensitivity and functional performance of the rectum. |
15 | $71 | $348 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $107 | $379 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
14 | $119 | $1,318 |
| Esophageal function monitoring via capsule This procedure involves monitoring and recording the function of the esophagus using a small capsule attached to the esophageal wall. |
12 | $66 | $329 |
| Esophageal function monitoring via nasal tube This procedure involves prolonged monitoring and recording of esophageal function using a nasal tube equipped with an electrode. |
12 | $45 | $229 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $46 | $223 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$922,233
Total received (2018-2024)
Avg $131,748/year across 7 years
Top 0% in TX for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
880
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$170,466
2023
$153,775
2022
$117,461
2021
$130,529
2020
$104,708
2019
$99,966
2018
$145,327
Payments by company (2024)
Phathom Pharmaceuticals, Inc.
$74,631
Ardelyx, Inc.
$29,424
Regeneron Healthcare Solutions, Inc.
$24,359
QOL Medical, LLC
$8,641
Alnylam Pharmaceuticals Inc.
$6,660
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$6,157
AstraZeneca Pharmaceuticals LP
$5,720
AstraZeneca UK Limited
$5,638
ABBVIE INC.
$5,047
Iterative Scopes, Inc.
$1,899
Olympus Medical Systems Corporation
$1,240
AstraZeneca AB
$537
CONMED Corporation
$270
Vibrant Gastro, Inc.
$142
Janssen Biotech, Inc.
$99
Top 3 companies account for 75.3% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$144,671
Phathom Pharmaceuticals, Inc.
$79,631
Ardelyx, Inc.
$75,549
QOL Medical, LLC
$69,346
Allergan Inc.
$68,428
Takeda Pharmaceuticals U.S.A., Inc.
$56,941
Alnylam Pharmaceuticals Inc.
$54,088
Shire North American Group Inc
$54,026
Medtronic, Inc.
$50,476
Regeneron Healthcare Solutions, Inc.
$43,221
AbbVie Inc.
$28,764
AstraZeneca Pharmaceuticals LP
$27,258
RedHill Biopharma Inc.
$24,880
GENZYME CORPORATION
$16,881
Covidien LP
$15,623
PFIZER INC.
$14,582
Synergy Pharmaceuticals Inc
$12,688
AstraZeneca UK Limited
$12,638
Alexion Pharmaceuticals, Inc.
$12,075
ABBVIE INC.
$10,932
Endo Pharmaceuticals Inc.
$9,187
Sebela Pharmaceuticals Inc.
$8,400
Alfasigma USA, Inc.
$5,835
PORTOLA PHARMACEUTICALS, INC.
$3,863
US WorldMeds, LLC
$3,806
Iterative Scopes, Inc.
$2,799
Pfizer Inc.
$2,759
Olympus Corporation
$2,160
AstraZeneca AB
$2,148
Allergan, Inc.
$1,666
Olympus Medical Systems Corporation
$1,240
Daiichi Sankyo Inc.
$1,074
Mauna Kea Technologies, Inc.
$1,000
Aries Pharmaceuticals, Inc.
$974
PENTAX of America, Inc.
$654
Vibrant Gastro, Inc.
$618
CONMED Corporation
$488
Janssen Scientific Affairs, LLC
$124
Boston Scientific Corporation
$124
ERBE USA Inc
$116
Ironwood Pharmaceuticals, Inc
$100
Janssen Biotech, Inc.
$99
Mahana Therapeutics, Inc.
$87
AnX Robotica Corp
$76
Ethicon US, LLC
$68
Nestle HealthCare Nutrition Inc.
$39
BOSTON SCIENTIFIC CORPORATION
$30
Top 3 companies account for 32.5% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · ANDEXXA · Andexxa · Barrx · C2 CryoBalloon · COLOGUARD · CONMED BILIARY · CONMED Biliary · CONMED GENERATORS · DUPIXENT · ERBE · EVIS EXERA III VIDEO SYSTEM CENTER · Emprint · GENERAL - THERAPIES · GIVLAARI · GIVLARRI · IBSRELA · INFLECTRA · INTERSTIM · LINX Reflux Management System · LINZESS · MOTEGRITY · MOVANTIK · Mahana IBS · Movantik · NASCOBAL · PLENVU · PillCam · RELISTOR · RELISTOR ORAL · REMIMAZOLAM · RESOLUTION CLIP · RIFAXIMIN · RINVOQ · SKOUT · SKOUT System · SKYRIZI · STELARA · SUCRAID · Sucraid · TALICIA · TRULANCE · Talicia · Trulance · UCERIS · VIBERZI · VIO300D; APC2; EJ2 · VOQUEZNA · Vibrant Starter Kit · XIFAXAN · ZENPEP · Zelnorm
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
251
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cash is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cash experienced with esophageal motility study?
Based on Medicare claims data, Dr. Cash performed 72 esophageal motility study services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cash receive payments from pharmaceutical companies?
Yes. Dr. Cash received a total of $922,233 from 47 companies across 880 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cash's costs compare to other gastroenterologists in Houston?
Dr. Cash's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Houston
Browse gastroenterologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in TX
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in TX
Which TX gastroenterologists receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Phathom Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Phathom Pharmaceuticals, Inc.
By company
Ardelyx, Inc. Payments to Doctors
See all physicians who received payments from Ardelyx, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology